Abstract:Bis(isopropoxo) Ti(IV) complexes of diamino bis(phenolato) "salan" ligands were prepared, their hydrolysis in 1:9 water/THF solutions was investigated, and their cytotoxicity toward colon HT-29 and ovarian OVCAR-1 cells was measured. In particular, electronic effects at positions ortho and para to the binding phenolato unit were analyzed. We found that para substituents of different electronic features, including Me, Cl, OMe, and NO(2), have very little influence on hydrolysis rate, and all para-substituted or… Show more
“…This rearrangement would change the overall charge of the compound from neutral to positive and may facilitate direct interaction with the DNA backbone through ionic interactions resulting in cell death (26). Another study shows that substitutions ortho to the binding phenolato unit of salan-type ligands influences the cytotoxicity of these types of Ti(IV) compounds because of electronic and steric effects (27). In addition, both the chirality of ligands (28) and ligand coordination to Ti(IV) (28,29) can affect the cytotoxicity of Ti(IV) compounds.…”
Titanium(IV) compounds are excellent anticancer drug candidates, but they have yet to find success in clinical applications. A major limitation in developing further compounds has been a general lack of understanding of the mechanism governing their bioactivity. To determine factors necessary for bioactivity, we tested the cytotoxicity of different ligand compounds in conjunction with speciation studies and mass spectrometry bioavailability measurements. These studies demonstrated that the Ti(IV) compound of N, N′-di(o-hydroxybenzyl)ethylenediamine-N,N′-diacetic acid (HBED) is cytotoxic to A549 lung cancer cells, unlike those of citrate and naphthalene-2,3-diolate. Although serum proteins are implicated in the activity of Ti(IV) compounds, we found that these interactions do not play a role in [TiO(HBED)] − activity. Subsequent compound characterization revealed ligand properties necessary for activity. These findings establish the importance of the ligand in the bioactivity of Ti(IV) compounds, provides insights for developing next-generation Ti(IV) anticancer compounds, and reveal [TiO (HBED)] − as a unique candidate anticancer compound.drug delivery | transferrin | albumin | metal-based anticancer compounds
“…This rearrangement would change the overall charge of the compound from neutral to positive and may facilitate direct interaction with the DNA backbone through ionic interactions resulting in cell death (26). Another study shows that substitutions ortho to the binding phenolato unit of salan-type ligands influences the cytotoxicity of these types of Ti(IV) compounds because of electronic and steric effects (27). In addition, both the chirality of ligands (28) and ligand coordination to Ti(IV) (28,29) can affect the cytotoxicity of Ti(IV) compounds.…”
Titanium(IV) compounds are excellent anticancer drug candidates, but they have yet to find success in clinical applications. A major limitation in developing further compounds has been a general lack of understanding of the mechanism governing their bioactivity. To determine factors necessary for bioactivity, we tested the cytotoxicity of different ligand compounds in conjunction with speciation studies and mass spectrometry bioavailability measurements. These studies demonstrated that the Ti(IV) compound of N, N′-di(o-hydroxybenzyl)ethylenediamine-N,N′-diacetic acid (HBED) is cytotoxic to A549 lung cancer cells, unlike those of citrate and naphthalene-2,3-diolate. Although serum proteins are implicated in the activity of Ti(IV) compounds, we found that these interactions do not play a role in [TiO(HBED)] − activity. Subsequent compound characterization revealed ligand properties necessary for activity. These findings establish the importance of the ligand in the bioactivity of Ti(IV) compounds, provides insights for developing next-generation Ti(IV) anticancer compounds, and reveal [TiO (HBED)] − as a unique candidate anticancer compound.drug delivery | transferrin | albumin | metal-based anticancer compounds
“…Nevertheless, numerous attempts to isolate pure LTiX 2 precursors failed; the water presumably originating from ligand preparation despite extensive purifications attempts (see SI), was sufficient to yield only hydrolysis products. The hydrolytic stability of the binuclear complexes was analyzed by 1 H NMR, adding 10% D 2 O to a DMSO-d 6 solution of the complexes, as previously described [15,16]. All salophan-Ti IV complexes were found to be highly stable, with t 1/2 above 100 h as expected for O-bridged clusters with no labile ligands [15,16,22,23,26].…”
mentioning
confidence: 99%
“…Complexes of Ti IV , budotitane ((bzac) 2 Ti(OEt 2 ), titanocene dichloride (Cp 2 TiCl 2 ) and their derivatives exhibited high anti-cancer properties against a range of cell lines with relatively minor side effects; nevertheless, rapid hydrolysis of the complexes in biologically relevant solutions to multiple unidentified species inhibited their utility [2][3][4][5][6][7][8][9][10][11][12][13]. Previously we have presented the diaminobis(phenolato) Ti IV complexes with particularly high cytotoxic activity, demonstrating higher hydrolytic stability than that of budotitane and titanocene dichloride [14][15][16][17][18][19][20][21][22][23][24][25]. Structure-activity relationship studies revealed that, for example, methyl groups on the nitrogen atoms (N-Me) greatly improve the hydrolytic stability of the complexes compared with no substitution (N-H) [22].…”
mentioning
confidence: 99%
“…Structure-activity relationship studies revealed that, for example, methyl groups on the nitrogen atoms (N-Me) greatly improve the hydrolytic stability of the complexes compared with no substitution (N-H) [22]. Subsequent studies suggested that the active species are polynuclear O-bridged hydrolysis products [26]: trinuclear species for N-Me complexes [15,16] and binuclear species for N-H complexes [22,23], thus eliminating the need for labile ligands. The polynuclear hydrolysis products mostly showed anticancer activity only in particular nano-formulations, due to diminished accessibility and solubility [26,27].…”
mentioning
confidence: 99%
“…The organic phase was evacuated to give the red product, which was heated overnight at 60°C (0.33 g, 26%). 1 LTi(OiPr) 2 compounds [16,22] by mixing the ligand with 1 equiv. of Ti(OiPr) 4 in THF at room temperature and stirring for at least 2 h. 2 The complexes were analyzed by 1 H NMR that suggested the formation of binuclear Ti IV compounds with similar number of signals but at different chemical shifts, without any indications of labile isopropoxo ligands.…”
The present contribution summarizes and highlights the essential coordination features and applications of salen‐supported metal complexes. The use of salen complexes in homogeneous (and asymmetric) catalysis constitutes a major part of this chapter as salen‐type (and closely related) ligands have undoubtedly established themselves as “privileged” supporting ligands in catalysis over the past 20 years.
The interest of such tetradentate chelating ligands in various other applications, including the suitability of salen metal complexes for medical applications and as building blocks for the synthesis of well‐defined polymetallic assemblies, will also be briefly discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.